跳至主要内容
临床试验/ISRCTN82731440
ISRCTN82731440已完成未知

A randomised controlled trial to investigate the clinical and cost effectiveness of adding an ablation device-based maze procedure as a routine adjunct to elective cardiac surgery for patients with pre-existing atrial fibrillation

Papworth Hospital NHS Foundation Trust (UK)0 个研究点目标入组 352 人开始时间: 2008年4月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
352

研究概览

简要总结

2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29701167 results 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35348642/ five-year results (added 30/03/2022)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age over 18, both males and females
  • 2. Patients will have elective cardiac surgery planned (coronary surgery, valve surgery, combined coronary and valve surgery, any other cardiac surgery requiring cardiopulmonary bypass)
  • 3. Patients will have a history of documented atrial fibrillation (chronic, persistent or paroxysmal) beginning more than 3 months before entry into the study
  • 4. All patients will provide written informed consent to participation

排除标准

  • 1. Patients with previous cardiac operations
  • 2. Patients having emergency or salvage cardiac operations
  • 3. Patients whose surgery will not involve cardiopulmonary bypass
  • 4. Patients who are unlikely to be available for follow-up over a two-year period
  • 5. Patients who are deemed not competent to provide consent

研究者

发起方
Papworth Hospital NHS Foundation Trust (UK)

相似试验